Boston Scientific Announces Results For Second Quarter 2021
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall St set to open higher as tech rebounds, Micron earnings eyed
- Brent hits lowest since before start of Iran war on expectations of smoother oil flows via Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Boston Scientific (BSX) PT Raised to $53 at Cowen
July 27, 2021 3:54 PM EDTCowen analyst Joshua Jennings raised the price target on Boston Scientific (NYSE: BSX) to $53.00 (from $47.00) while maintaining an Outperform rating.
The analyst commented, "BSX posted 2Q revenue and EPS of $3.08B and $0.40, beating Street estimates of $2.94B and $0.37. Organic sales growth was 9% compared to... More
Boston Scientific (BSX) Tops Q2 EPS by 3c
July 27, 2021 6:34 AM EDTBoston Scientific (NYSE: BSX) reported Q2 EPS of $0.40, $0.03 better than the analyst estimate of $0.37. Revenue for the quarter came in at $3.08 billion versus the consensus estimate of $2.94 billion.
GUIDANCE:
Boston Scientific sees FY2021 EPS of $1.58-$1.62, versus the consensus of... More
